In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...

For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...

Flu, viral fever, and COVID-19 all cause fever and respiratory symptoms, but key differences in onset, symptom patterns, ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...

The World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for ...

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...